{"id":"W3045363217","doi":"10.1007/s40263-020-00749-x","title":"Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study","year":2020,"lang":"en","type":"article","venue":"CNS Drugs","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Bayer HealthCare; Teva Pharmaceutical Industries; Biogen; Celgene; Sanofi","keywords":"Alemtuzumab; Medicine; Multiple sclerosis; Neurology; Interferon beta-1a; Internal medicine; Post-hoc analysis; Clinical trial; Interferon beta; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005109163,0.0009111566,0.002042297,0.0005218113,0.0004366949,0.001247368,0.0008758878,0.0007492569,0.00161716],"category_scores_gemma":[0.004420015,0.0002937034,0.002932353,0.0005103819,0.0005509226,0.0008273701,0.0008995476,0.001291504,0.0002331216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005353094,"about_ca_system_score_gemma":0.0006317132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0011466,"about_ca_topic_score_gemma":0.00125042,"domain_scores_codex":[0.9976565,0.00113881,0.0001515967,0.0005320432,0.0002166595,0.0003043006],"domain_scores_gemma":[0.9961605,0.00129056,0.0009923032,0.000526665,0.0003873823,0.0006426005],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5806978,0.001590658,0.3908722,0.0003363351,0.01169394,0.0002322768,0.0003074258,0.001142951,0.002303458,0.000100643,0.0008833311,0.009838945],"study_design_scores_gemma":[0.0282983,0.05501325,0.9011737,0.00006277588,0.009468743,0.0003001303,0.0002145405,0.002858495,0.001038142,0.0001761697,0.001338861,0.00005704819],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986583,0.0006959451,0.00005756411,0.00002163594,0.00001322863,0.00005681896,0.0002881735,0.000005002279,0.0002033945],"genre_scores_gemma":[0.9987716,0.00009422295,0.00006288524,0.00003127006,0.0000324533,0.00005621064,0.0007650211,0.000003437108,0.0001827634],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005109163,"threshold_uncertainty_score":0.02702016,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01718048180492521,"score_gpt":0.2825230293991739,"score_spread":0.2653425475942487,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}